Health

Vertex Pharmaceuticals

$237.59
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.05 (-0.44%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell VRTX and other stocks, options, and ETFs commission-free!

About VRTX

Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA. The listed name for VRTX is Vertex Pharmaceuticals Incorporated Common Stock.

CEO
Reshma Kewalramani
Employees
3,000
Headquarters
Boston, Massachusetts
Founded
1989
Market Cap
61.28B
Price-Earnings Ratio
23.25
Dividend Yield
—
Average Volume
1.76M
High Today
$241.83
Low Today
$236.76
Open Price
$236.93
Volume
1.26M
52 Week High
$306.08
52 Week Low
$197.47

Collections

VRTX Earnings

$0.00
$0.88
$1.76
$2.64
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Feb 1, After Hours

You May Also Like

MRGR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure